Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cognitive Dysfunction × Hormones × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Dementia 1 Cognitive Dysfunction 1 Brain Neoplasms 1 Anxiety Disorders 1 Anomia 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Alzheimer Disease 1

Interventions

mazdutide 1 enzalutamide 1 Standard of Care 1 Ramipril 1 Prednisone 1 Hormones 1 Gonadotropin-Releasing Hormone 1 Exercise 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05894954 2026-02-18

EVANTHEA

Alzheimer's Prevention and Reversal Project, Inc.

Phase 3 Completed

Alzheimer Disease, Anomia, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡